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Embryonic Stem Cells (ESCs)
undifferentiated cells derived from a preimplantation embryo (inner
cell mass of blastocyst) that are capable of self-renewal, and can
develop into cells and tissues of the three primary germ layers
Adult Stem Cells (ASCs)
undifferentiated cells, found in tissues or
organs of the body after embryonic
development, that are capable of self-
renewal and differentiate into specialized






Adaptado de O’Connor & Crystal 2006, Nature Reviews Genetics 7, 261-276
Induced Pluripotent Stem Cells (iPSC)
Yamanaka’s Lab (Japan)
Takahashi, K. et al. (2007) Induction of pluripotent stem cells
from adult human fibroblasts by defined factors. Cell 131,
861–872
Thomson’s Lab (USA)
Yu, J. et al. (2007) Induced pluripotent stem cell lines derived
from human somatic cells. Science 318, 1917–1920.
Oct4; Sox2; Klf4; Myc
Oct4; Sox2; Nanog; Lin28





































































































‐ PRODUCTION OF IPSC‐DERIVED CMS: MAJOR ACHIEVEMENTS
The use of environmentally controlled bioreactors is critical to ensure
EFFICIENT and SCALABLE production of functional cardiomyocytes




















































































































































































































































































































































































































































































































































 After expansion in bioreactors operating in
continuous perfusion, cells maintained their
identity, morphology and differentiation potential.



















































































































‐ USP OF hMSC: CELL EXPANSION
www.ibet.pt40














































































































































































































































































































































700 175 85 38
1500 375 92 62











































‐ DSP OF hMSC: CELL CONCENTRATION
Cunha B et al 2015, Journal of Membrane Science, 478:117‐129 
Impact of the shear rate on the concentration process: 

















































































‐ DSP OF hMSC: CELL WASHING































































































































































 hMSCmaintained their immunophenotype and metabolic activity after processing;
 Ability to adhere to plastic surfaces and proliferative capacity (PDL = 3) after re‐plating
www.ibet.pt55
‐ hMSC: PROCESS INTEGRATION – QUALITY ASSAYS
Differentiation Potential
Morphology























































































“The cell therapy industry has an opportunity to learn from protein 
processing and anticipate Upstream & DSP bottlenecks by proactively 
developing technologies to address future scales.”
Adapted fromPattasseril et al (2013) 
